ANI Pharmaceuticals Financial Overview
ANI Pharmaceuticals's market cap is currently $1.85B. The company's EPS TTM is $2.04; its P/E ratio is 50.80; ANI Pharmaceuticals is scheduled to report earnings on November 10, 2025, and the estimated EPS forecast is $1.98. See an overview of income statement, balance sheet, and cash flow financials.
